for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BioLife Solutions Inc

BLFS.OQ

Latest Trade

15.55USD

Change

0.00(0.00%)

Volume

65,211

Today's Range

14.94

 - 

16.19

52 Week Range

9.19

 - 

22.38

As of on the NASDAQ ∙ Minimum 15 minute delay

Latest Developments

Biolife Solutions Reports Q3 Earnings Per Share $0.37

Nov 12 (Reuters) - Biolife Solutions Inc <BLFS.O>::BIOLIFE SOLUTIONS ANNOUNCES THIRD QUARTER 2019 FINANCIAL RESULTS.Q3 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.01.Q3 GAAP EARNINGS PER SHARE $0.37.Q3 REVENUE ROSE 25 PERCENT TO $6.6 MILLION.SEES FY 2019 REVENUE $27.5 MILLION TO $31.5 MILLION.SEES FY 2020 REVENUE $50 MILLION TO $56 MILLION.SEES FY 2020 REVENUE UP 69 TO 90 PERCENT.AFFIRMED EXPECTATION FOR FULL-YEAR POSITIVE ADJUSTED OPERATING INCOME, ADJUSTED NET INCOME AND ADJUSTED EBITDA.

Biolife Solutions Q2 Adjusted Earnings Per Share $0.04

Aug 8 (Reuters) - Biolife Solutions Inc <BLFS.O>::BIOLIFE SOLUTIONS ANNOUNCES SECOND QUARTER 2019 FINANCIAL RESULTS.Q2 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.04.Q2 GAAP EARNINGS PER SHARE $0.03.Q2 REVENUE ROSE 29 PERCENT TO $6.7 MILLION.SEES FY 2019 REVENUE $27.5 MILLION TO $30.5 MILLION.FY2019 REVENUE VIEW $28.2 MILLION -- REFINITIV IBES DATA.FOR 2019 GROSS MARGIN IS EXPECTED TO BE IN A RANGE OF 69% TO 70% ON A GAAP AND NON-GAAP BASIS, COMPARED WITH 69% IN 2018.

BioLife Solutions To Acquire SAVSU Technologies

July 8 (Reuters) - Biolife Solutions Inc <BLFS.O>::BIOLIFE SOLUTIONS TO ACQUIRE SAVSU TECHNOLOGIES.BIOLIFE SOLUTIONS INC - ACQUISITION WILL BE PURSUANT TO A SHARE PURCHASE AGREEMENT AND IS EXPECTED TO CLOSE WITHIN 45 DAYS..BIOLIFE SOLUTIONS INC - EXERCISED ITS OPTION TO ACQUIRE REMAINING 56% OF OUTSTANDING SHARES OF PRIVATELY HELD SAVSU TECHNOLOGIES.BIOLIFE SOLUTIONS INC - DEAL INCLUDES ALL SAVSU INTELLECTUAL PROPERTY COMPRISED OF 15 PENDING, ISSUED U.S. PATENTS RELATED TO COLD CHAIN TECHNOLOGIES.BIOLIFE SOLUTIONS INC - TWENTY-THREE SAVSU EMPLOYEES ARE JOINING BIOLIFE TEAM.BIOLIFE SOLUTIONS INC - SAVSU ALSO HAS A CONTRACT SALES ORGANIZATION COVERING EUROPE.

BioLife Solutions Q4 Earnings Per Share $0.04

March 14 (Reuters) - Biolife Solutions Inc <BLFS.O>::BIOLIFE SOLUTIONS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS.Q4 EARNINGS PER SHARE $0.04.Q4 REVENUE $5.5 MILLION.SEES FY 2019 REVENUE $27 MILLION TO $30 MILLION.

Biolife Solutions Expands Cell And Gene Therapy Tools Portfolio With Acquisition Of Astero Bio

Biolife Solutions Inc <BLFS.O>::BIOLIFE SOLUTIONS EXPANDS CELL AND GENE THERAPY TOOLS PORTFOLIO WITH ACQUISITION OF ASTERO BIO.BIOLIFE SOLUTIONS INC - PROVIDES ACCESS TO ADDRESSABLE MARKET PROJECTED TO EXCEED $150 MILLION BY 2024.BIOLIFE SOLUTIONS INC - PROPOSED DEAL FOR UPFRONT CASH PAYMENT OF $8.0 MILLION.BIOLIFE SOLUTIONS INC - GAINS PRODUCTS THAT AUTOMATE THAWING PROCESS FOR HIGH-VALUE BIOLOGIC THERAPIES.BIOLIFE SOLUTIONS INC - ENTERED INTO AN AGREEMENT TO ACQUIRE ASTERO BIO CORPORATIO FOR AN UPFRONT CASH PAYMENT OF $8.0 MILLION.

Biolife Solutions Reports Q3 Earnings Per Share Of $0.05

Nov 8 (Reuters) - Biolife Solutions Inc <BLFS.O>::BIOLIFE SOLUTIONS ANNOUNCES THIRD QUARTER 2018 FINANCIAL RESULTS.Q3 EARNINGS PER SHARE $0.05.Q3 REVENUE ROSE 79 PERCENT TO $5.3 MILLION.BIOLIFE SOLUTIONS - AFFIRMING BIOPRESERVATION MEDIA REVENUE GUIDANCE FOR FY 2018 OF $19 MILLION TO $20 MILLION, REPRESENTING GROWTH OF 72% TO 82% OVER 2017.

Biolife Solutions Reports Q3 Revenue Rose 79 Pct To $5.3 Mln

Oct 1 (Reuters) - Biolife Solutions Inc <BLFS.O>::BIOLIFE SOLUTIONS REPORTS RECORD THIRD QUARTER 2018 PRELIMINARY REVENUE OF $5.3 MILLION, UP 79% YEAR-OVER-YEAR.Q3 REVENUE ROSE 79 PERCENT TO $5.3 MILLION.SEES 2018 BIOPRESERVATION MEDIA REVENUE TO BE IN A RANGE OF $19 MILLION TO $20 MILLION.ENDED QUARTER WITH $32.4 MILLION IN CASH.

Biolife Solutions Reports Q2 Earnings Per Share $0.05

Aug 9 (Reuters) - BioLife Solutions Inc <BLFS.O>::BIOLIFE SOLUTIONS ANNOUNCES SECOND QUARTER 2018 FINANCIAL RESULTS.Q2 EARNINGS PER SHARE $0.05.Q2 REVENUE ROSE 102 PERCENT TO $5.2 MILLION.AFFIRMED GUIDANCE FOR FULL-YEAR GAAP OPERATING PROFIT.ANTICIPATE FULL-YEAR 2018 GAAP NET INCOME.AFFIRMED GUIDANCE FOR BIOPRESERVATION MEDIA REVENUE TO BE BETWEEN $18.5 MILLION AND $20.0 MILLION.

Biolife Solutions Q2 Revenue Rose 103 Pct To $5.2 Mln

July 2 (Reuters) - BioLife Solutions Inc <BLFS.O>::BIOLIFE SOLUTIONS REPORTS SECOND QUARTER 2018 PRELIMINARY REVENUE OF $5.2 MILLION, UP 103% YEAR-OVER-YEAR AND 36% SEQUENTIALLY.Q2 REVENUE ROSE 103 PERCENT TO $5.2 MILLION.SAYS BIOPRESERVATION MEDIA REVENUE IS NOW EXPECTED TO BE IN A RANGE OF $18.5 MILLION TO $20 MILLION FOR FY 2018.SAYS FY 2018 GROSS MARGIN IS EXPECTED TO BE BETWEEN 63% AND 65%, UP FROM 61% FOR 2017.

BioLife Solutions Reports Q1 Loss Per Share $0.01

May 10 (Reuters) - BioLife Solutions Inc <BLFS.O>::BIOLIFE SOLUTIONS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.01.Q1 REVENUE ROSE 61 PERCENT TO $3.8 MILLION.AFFIRMING BIOPRESERVATION MEDIA REVENUE IS NOW EXPECTED TO RANGE BETWEEN $14.5 MILLION TO $15.5 MILLION FOR 2018.AFFIRMING FULL-YEAR GAAP OPERATING PROFIT, WITH PROPORTIONAL INCREASES IN ADJUSTED EBITDA AND CASH FLOW FROM OPERATIONS.INCREASING 2018 GROSS MARGIN GUIDANCE TO 63% TO 65%.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up